An uncommon coronary artery fistula.

Cardiovasc Revasc Med

Interventional Cardiology Unit, Division of Cardiology, Rovigo General Hospital, Rovigo, Italy.

Published: May 2006

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2005.07.003DOI Listing

Publication Analysis

Top Keywords

uncommon coronary
4
coronary artery
4
artery fistula
4
uncommon
1
artery
1
fistula
1

Similar Publications

Background: Cardiomyopathy is a disease that affects the myocardium and can be classified as dilated, restrictive, or hypertrophic cardiomyopathy. Among the subtypes, restrictive cardiomyopathy is characterized by restriction of ventricular filling and its uncommon cause is a disease due to mutation on Filamin C (FLNC) gene. Filamin C is an actin-binding protein encoded by FLNC gene and participates in sarcomere stability maintenance, which is expressed on the striated muscle.

View Article and Find Full Text PDF
Article Synopsis
  • PAH can cause serious ocular conditions like CRVO and CilRAO due to high blood pressure in the lungs affecting blood flow to the eyes.
  • A 13-year-old girl with a history of heart surgery experienced sudden vision loss, with tests revealing both CRVO and CilRAO, along with signs of severe PAH.
  • Treatment with Bosentan and traditional Chinese medicine led to significant vision improvement, highlighting the importance of addressing cardiovascular issues to prevent eye complications and the need for a comprehensive approach in such complex cases.
View Article and Find Full Text PDF
Article Synopsis
  • Coronary artery ectasia (CAE) is a rare condition usually found during coronary angiography and can increase the risk of blood clots.
  • A 40-year-old male with acute coronary syndrome experienced a complete blockage in his ectatic left circumflex artery and the dominant right coronary artery.
  • After thrombus aspiration restored normal blood flow, the case highlights the difficulties in treating acute coronary syndrome in patients with CAE and stresses the need for further research on effective treatment methods.
View Article and Find Full Text PDF

Transcatheter Aortic Valve Replacement in Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis.

Catheter Cardiovasc Interv

January 2025

Division of Cardiovascular Diseases, Bridgeport Hospital, Yale New Haven Health, Bridgeport, Connecticut, USA.

Background: The co-existence of severe aortic stenosis (AS) and hypertrophic cardiomyopathy (HCM) is not uncommon. Surgical intervention is the gold standard management. Patients with high surgical risk might undergo transcatheter aortic valve replacement (TAVR).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!